2021 Presentations

Physician Slides – Grand 4&5

  • T. HOWARD LEE KEYNOTE LECTURE: STATE OF THE ART: CURRENT AND EMERGING TREATMENT OF HODGKIN’S LYMPHOMA – Ranjana Advani, MD
  • MULTIPLE MYELOMA: THE CURE AROUND THE CORNER – Kenneth Anderson, MD
  • STATE OF THE ART: 2021 EMERGING THERAPIES IN HEMATOLOGIC MALIGNANCIES – Ruemu Ejedafeta Birhiray, MD
  • TREATMENT OF RELAPSED/ REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA IN 2021: THE CHESON APPROACH – Bruce D. Cheson, M.D., FACP, FAAAS, FASCO
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION: UPDATING THE OLD CLOSET – Richard Childs, M.D
  • ACUTE MYELOID LEUKEMIA: FINALLY, A TRIP BEYOND 7+3 – Harry Erba, MD

  • ACUTE LYMPHOBLASTIC LEUKEMIA: BIOLOGIC AND TARGETED THERAPY – Hagop M. Kantarjian, MD
  • BENIGN HEMATOLOGY: CLOTTING, BLEEDING AND MORE – Craig Kessler, MD
  • CHRONIC MYELOID LEUKEMIA: THERAPY UPDATED AND MODIFIED FOR 2021 – Richard Larson, MD
  • AGGRESSIVE B AND T CELL LYMPHOMAS: EMERGING THERAPIES – John Leonard, MD
  • MYELOPROLIFERATIVE NEOPLASMS: RISK STRATIFICATION AND THERAPY; A 2021 GLOBAL PERCEPTIVE – Ruben Mesa, MD, FACP
  • INDOLENT AND MANTLE CELL LYMPHOMA: UPDATING THE TOOLBOX, INCLUDING AND BEYOND ANTI-CD20 ANTIBODIES – Sonali M. Smith, MD
  • MYELODYSPLASTIC SYNDROME: EMERGING AND TARGETED THERAPIES – Richard Stone, MD
  • MASTOCYTOSIS AND EOSINOPHILIA: THE VEXING DISORDERS OF THE BLOOD – Ayalew Tefferi, MD
  • WALDENSTRÖM’S MACROGLOBULINEMIA: TARGETING FOR THE BIG KILL – Steven Treon, MD, MA, PhD, FACP, FRCP
  • CHALLENGING CASES PRESENTATION – Michael C. Wiemann, MD, FACP
  • CHRONIC LYMPHOCYTIC LEUKEMIA: CURABILITY AND DURATION OF THERAPY – Jennifer Woyach, MD


    • Nursing & Allied Provider Slides – Capitol 2

  • CHRONIC LYMPHOCYTIC LEUKEMIA – Steven Coutre, MD
  • MULTIPLE MYELOMA AND WALDENSTRÖM’S – Morie Gertz, MD, MACP
  • BENIGN HEMATOLOGY AND COAGULOPATHY – Craig Kessler, MD
  • AGGRESSIVE LYMPHOMAS – John Leonard, MD
  • MYELOPROLIFERATIVE NEOPLASMS –
    Ruben Mesa, MD, FACP
  • MANAGEMENT OF LONG-TERM SURVIVORS OF HEMATOLOGIC MALIGNANCIES – Kristi Orbaugh, RN, MSN RNP, AOCN
  • RECOGNIZING TOXICITIES OF ORAL ONCOLYTICS IN THE MANAGEMENT OF HEMATOLOGIC MALIGNANCIES – David Reeves, PharmD, BCOP
  • INDOLENT LYMPHOMAS AND HODGKIN’S LYMPHOMA – Sonali M. Smith, MD